Stockscreener 앱 받기
3.68
2.79%
0.10
시장 영업 전:
3.77
0.09
+2.45%
전일 마감가:
$3.58
열려 있는:
$3.55
하루 거래량:
38,868
Relative Volume:
0.02
시가총액:
$90.33M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.79%
1개월 성능:
+2.51%
6개월 성능:
+86.80%
1년 성능:
-71.07%
1일 변동 폭
$3.51
$3.69
1주일 범위
$3.28
$3.78
52주 변동 폭
$1.47
$13.14
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
명칭
Artiva Biotherapeutics Inc
전화
(858) 267-4467
주소
5505 MOREHOUSE DRIVE, SAN DIEGO
ARTV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
3.68 | 87.87M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-11 | 재개 | H.C. Wainwright | Buy |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-13 | 개시 | Jefferies | Buy |
| 2024-08-13 | 개시 | Needham | Buy |
| 2024-08-13 | 개시 | TD Cowen | Buy |
| 2024-08-13 | 개시 | Wedbush | Outperform |
모두보기
Artiva Biotherapeutics Inc 주식(ARTV)의 최신 뉴스
How Artiva Biotherapeutics Inc. stock trades before earningsPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - Newser
Will Artiva Biotherapeutics Inc. stock outperform tech sector in 2025Trade Exit Report & Consistent Profit Trading Strategies - Newser
Risk Hedge: Can Artiva Biotherapeutics Inc. stock rebound after recent weakness2025 Institutional Moves & Daily Growth Stock Tips - moha.gov.vn
Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessDividend Hike & Free Technical Confirmation Trade Alerts - BỘ NỘI VỤ
Will Artiva Biotherapeutics Inc. stock gain from lower inflationJuly 2025 Summary & Safe Capital Growth Trade Ideas - moha.gov.vn
A new trading data show Allarity Therapeutics Inc (ALLR) is showing positive returns. - Setenews
Analysts Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Target Price at $19.00 - Defense World
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Artiva Biotherapeutics Inc. stock is seen as undervalued2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com
Will Artiva Biotherapeutics Inc. stock beat EPS estimatesJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - newser.com
How resilient is Artiva Biotherapeutics Inc. stock in market downturnsWeekly Investment Report & Expert Curated Trade Ideas - newser.com
Is Artiva Biotherapeutics Inc. stock attractive for retirement portfoliosWeekly Market Report & Weekly Consistent Profit Watchlists - newser.com
Why Artiva Biotherapeutics Inc. stock could rally in 2025 - newser.com
Artiva Biotherapeutics Inc. stock daily chart insights2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Is Artiva Biotherapeutics Inc. stock supported by strong cash flows2025 Investor Takeaways & Long-Term Growth Portfolio Plans - newser.com
ARTV: Off-the-shelf NK cell therapy for autoimmune disease advances toward pivotal RA trial with strong safety and funding - TradingView
Aslan Fred sells Artiva Biotherapeutics (ARTV) stock for $21,522 By Investing.com - Investing.com UK
Relative strength of Artiva Biotherapeutics Inc. in sector analysisSwing Trade & Free Weekly Watchlist of Top Performers - newser.com
Aslan Fred sells Artiva Biotherapeutics (ARTV) stock for $21,522 - Investing.com India
Artiva Biotherapeutics Reports Positive AlloNK Trial Results - MSN
Equities Analysts Offer Predictions for ARTV FY2025 Earnings - Defense World
Why Artiva Biotherapeutics Inc. stock is popular among millennialsPortfolio Update Summary & Real-Time Volume Analysis - newser.com
How to escape a deep drawdown in Artiva Biotherapeutics Inc.Quarterly Profit Review & High Accuracy Swing Entry Alerts - newser.com
Can Artiva Biotherapeutics Inc. stock resist sector downturnsQuarterly Earnings Summary & Verified Swing Trading Watchlist - newser.com
What risks investors should watch in Artiva Biotherapeutics Inc. stock2025 Winners & Losers & Low Risk Entry Point Guides - newser.com
Published on: 2025-11-14 18:41:04 - newser.com
Why analysts remain bullish on Artiva Biotherapeutics Inc. stockJuly 2025 Macro Moves & Daily Growth Stock Investment Tips - newser.com
HC Wainwright Forecasts Strong Price Appreciation for Artiva Biotherapeutics (NASDAQ:ARTV) Stock - Defense World
Identifying reversal signals in Artiva Biotherapeutics Inc.2025 Bull vs Bear & Smart Money Movement Tracker - newser.com
Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development - TipRanks
HC Wainwright & Co. Maintains Artiva Biotherapeutics (ARTV) Buy Recommendation - Nasdaq
Promising Developments in Artiva Biotherapeutics’ AlloNK Therapy for Autoimmune Diseases - TipRanks
Buy Rating for Artiva Biotherapeutics, Inc. Based on Promising Clinical Results and Competitive Edge - TipRanks
Buy Rating for Artiva Biotherapeutics Based on Promising AlloNK Combination Therapy Results - TipRanks
Artiva Biotherapeutics Inc (ARTV) 재무 분석
Artiva Biotherapeutics Inc (ARTV)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.10%
1.10%
자본화:
|
볼륨(24시간):